机器人肾动脉瘤修复术
本文报告9例连续患者接受机器人肾动脉瘤修复术(共10个肾动脉瘤)的经验。中位动脉瘤直径2.2(1.8-3)cm,5例接受动脉内低温肾灌注。所有病例均机器人完成,无中转开放。中位随访16(2-67)个月,所有患者肾功能保留。作者认为机器人修复复杂肾动脉瘤可行,但需要相当的经验和专业技术。
要点
- 机器人修复复杂肾动脉瘤在技术上可行,无中转开放手术。
- 中位手术时间3.8(3-6)小时,中位热缺血时间26(19-32)分钟。
- 中位随访16(2-67)个月,所有患者肾功能保留。
核心结论
- 机器人修复复杂肾动脉瘤是可行的。
- 外科专业知识、患者选择和肾动脉瘤特异性血管重建是成功的关键。
- 需要更多经验来评估机器人修复肾动脉瘤的恰当地位。
研究设计与样本
- 单中心连续病例系列,9例连续患者接受机器人体内手术修复10个肾动脉瘤。
- 2例患者同期行机器人肾部分切除术,1例患者为孤立肾肾动脉瘤。
- 中位肾动脉瘤直径为2.2(1.8-3)cm。
- 5例患者接受了体内经动脉低温肾灌注。
- 机器人技术包括:定制动脉瘤切除及修复(n=5)、切除加端端吻合(n=2)、动脉瘤切除加分支再植入(n=1)、人工血管间置移植修复(n=1)和单纯肾切除术(n=1;该患者数据被排除在分析之外)。
主要发现
- 所有病例均通过机器人完成,无中转开放手术。
- 中位(范围)手术时间为3.8(3-6)小时,热缺血时间为26(19-32)分钟,低温肾灌注时间为34(29-69)分钟,估计失血量为100(25-400)ml。
- 术中无需输血。中位住院时间为3(2-6)天。
- 1例患者发生Clavien-Dindo II级并发症。
- 在中位随访16(2-67)个月时,所有患者肾功能保留;随访影像证实重建肾动脉管径正常、肾脏整体灌注,除外2个肾脏因有意结扎小极血管而出现小段梗死。
局限性
- 局限性包括患者数量少和研究为回顾性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Renal artery aneurysm (RAA) is a rare condition, traditionally managed with endovascular or open surgical techniques. OBJECTIVE: To report our experience with robotic RAA repair. DESIGN, SETTING, AND PARTICIPANTS: Nine consecutive patients underwent intracorporeal robotic surgery for 10 RAAs. SURGICAL PROCEDURE: Two patients underwent concomitant robotic partial nephrectomy. One patient had RAA in a solitary kidney. Median RAA diameter was 2.2 (1.8-3)cm. Intracorporeal transarterial hypothermic renal perfusion was performed in five patients. Robotic techniques included tailored aneurysmectomy and repair (n=5), excision with end-to-end anastomosis (n=2), aneurysmectomy with branch reimplantation (n=1), prosthetic interposition graft repair (n=1), and simple nephrectomy (n=1; this patient's data were excluded from analysis). MEASUREMENTS: Demographics, RAA characteristics, intraoperative techniques, perioperative outcomes, and follow up data were analyzed. Aneurysms were diagnosed by computed tomography, angiography, or incidentally during the performance of a partial nephrectomy. RESULTS AND LIMITATIONS: All cases were performed robotically, without conversion to open surgery. Median (range) operative time was 3.8 (3-6)h, warm ischemia time 26 (19-32)min, hypothermic renal perfusion time 34 (29-69)min, and estimated blood loss 100 (25-400)ml. No intraoperative blood transfusion was required. Median hospital stay was 3 (2-6)d. One patient had a Clavien-Dindo grade II complication. At median follow-up of 16 (2-67)mo, all patients had preserved renal function. Follow-up imaging confirmed normal caliber reconstructed renal arteries with globally perfused kidneys, except for two kidneys with small segmental infarcts due to an intentionally ligated small polar vessel. Limitations include the small number of patients and the retrospective nature of the study. CONCLUSIONS: Robotic repair of complex RAAs is feasible. Surgical expertise, patient selection, and RAA-specific vascular reconstruction are critical for success. Greater experience is needed to evaluate the proper place of robotic repair of RAAs. PATIENT SUMMARY: We report intracorporeal robotic repair for complex renal artery aneurysms. This robotic operation is feasible and safe, and replicates open principles. However, it requires considerable experience and expertise.
引用
- Abreu AL, Medina LG, Chopra S, et al. Robotic Renal Artery Aneurysm Repair. Eur Urol. 2019. PMID: 31248606. doi:10.1016/j.eururo.2019.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。